3,309 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Park Avenue Securities LLC

Park Avenue Securities LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,309 shares of the exchange traded fund’s stock, valued at approximately $268,000.

A number of other large investors have also recently bought and sold shares of XBI. Van ECK Associates Corp acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $1,497,000. Vontobel Holding Ltd. boosted its stake in SPDR S&P Biotech ETF by 5.4% during the 4th quarter. Vontobel Holding Ltd. now owns 6,893 shares of the exchange traded fund’s stock worth $621,000 after purchasing an additional 351 shares during the period. Bank Pictet & Cie Europe AG boosted its stake in SPDR S&P Biotech ETF by 28.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 9,110 shares of the exchange traded fund’s stock worth $820,000 after purchasing an additional 2,040 shares during the period. Principal Securities Inc. boosted its stake in SPDR S&P Biotech ETF by 37.9% during the 4th quarter. Principal Securities Inc. now owns 12,106 shares of the exchange traded fund’s stock worth $1,090,000 after purchasing an additional 3,325 shares during the period. Finally, Strategic Financial Concepts LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $2,447,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $83.60 on Monday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The stock has a market capitalization of $4.95 billion, a PE ratio of 11.47 and a beta of 0.85. The company has a fifty day moving average of $79.26 and a 200-day moving average of $86.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.